107 related articles for article (PubMed ID: 26426765)
1. Decreased expression of class III β-tubulin is associated with unfavourable prognosis in patients with malignant melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Melanoma Res; 2016 Feb; 26(1):29-34. PubMed ID: 26426765
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of β2-adrenergic receptor expression in malignant melanoma.
Shimizu A; Kaira K; Mori K; Kato M; Shimizu K; Yasuda M; Takahashi A; Oyama T; Asao T; Ishikawa O
Tumour Biol; 2016 May; 37(5):5971-8. PubMed ID: 26596834
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Neoplasma; 2016; 63(2):282-7. PubMed ID: 26774151
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
[TBL] [Abstract][Full Text] [Related]
5. Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells.
Akasaka K; Maesawa C; Shibazaki M; Maeda F; Takahashi K; Akasaka T; Masuda T
J Invest Dermatol; 2009 Jun; 129(6):1516-26. PubMed ID: 19122647
[TBL] [Abstract][Full Text] [Related]
6. Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line Chemotherapy.
Miyata Y; Matsuo T; Nakamura Y; Yasuda T; Ohba K; Takehara K; Sakai H
Anticancer Res; 2018 Mar; 38(3):1629-1635. PubMed ID: 29491095
[TBL] [Abstract][Full Text] [Related]
7. Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer.
Koh Y; Jang B; Han SW; Kim TM; Oh DY; Lee SH; Kang CH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Kim YW; Kim JH; Heo DS; Bang YJ
J Thorac Oncol; 2010 Mar; 5(3):320-5. PubMed ID: 20087230
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
[TBL] [Abstract][Full Text] [Related]
9. The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy.
Kaira K; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Ono A; Naito T; Tsuya A; Nakamura Y; Endo M; Kondo H; Nakajima T; Yamamoto N
Int J Clin Oncol; 2013 Jun; 18(3):371-9. PubMed ID: 22358390
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and pituitary homeobox 1 gene expression in the progression and prognosis of cutaneous malignant melanoma.
Barut F; Udul P; Kokturk F; Kandemir NO; Keser SH; Ozdamar SO
Kaohsiung J Med Sci; 2016 Oct; 32(10):494-500. PubMed ID: 27742032
[TBL] [Abstract][Full Text] [Related]
11. Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and β III-tubulin in thymic epithelial tumors.
Kaira K; Serizawa M; Koh Y; Miura S; Kaira R; Abe M; Nakagawa K; Ohde Y; Okumura T; Naito T; Murakami H; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
J Thorac Oncol; 2011 Mar; 6(3):606-13. PubMed ID: 21289518
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Pentheroudakis G; Batistatou A; Kalogeras KT; Kronenwett R; Wirtz RM; Bournakis E; Eleftheraki AG; Pectasides D; Bobos M; Papaspirou I; Kamina S; Gogas H; Koutras AK; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2011 May; 127(1):179-93. PubMed ID: 21390496
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers.
Person F; Wilczak W; Hube-Magg C; Burdelski C; Möller-Koop C; Simon R; Noriega M; Sauter G; Steurer S; Burdak-Rothkamm S; Jacobsen F
Tumour Biol; 2017 Oct; 39(10):1010428317712166. PubMed ID: 29022485
[TBL] [Abstract][Full Text] [Related]
14. Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
Mariani M; Shahabi S; Sieber S; Scambia G; Ferlini C
Curr Mol Med; 2011 Dec; 11(9):726-31. PubMed ID: 21999149
[TBL] [Abstract][Full Text] [Related]
15. Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.
Mariani M; Zannoni GF; Sioletic S; Sieber S; Martino C; Martinelli E; Coco C; Scambia G; Shahabi S; Ferlini C
Clin Cancer Res; 2012 May; 18(10):2964-75. PubMed ID: 22438565
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
17. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
[TBL] [Abstract][Full Text] [Related]
18. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM
Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470
[TBL] [Abstract][Full Text] [Related]
19. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of sex determining region Y-box 11 (SOX11) in cutaneous malignant melanoma.
Jian J; Guoying W; Jing Z
J Int Med Res; 2013 Aug; 41(4):1221-7. PubMed ID: 23867449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
